Location History:
- St. Louis, MO (US) (1991 - 1993)
- Ballwin, MO (US) (1996 - 1999)
Company Filing History:
Years Active: 1991-1999
Title: **Inventor Spotlight: Thomas Charles Riley, Jr.**
Introduction
Thomas Charles Riley, Jr. is a notable inventor based in Ballwin, Missouri, who has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, his innovative approach continues to impact the industry.
Latest Patents
Among his latest patents, Thomas has developed a long-acting GI and esophageal protectant. This bioadherent, orally ingestible system features a unique water-in-oil emulsion system comprising two phases: an internal hydrophilic phase constituting about 75% to 99% by volume, and an external hydrophobic phase comprising about 25% to 1% by volume. The external phase consists of a hydrophobic oil and an emulsifier with a hydrophilic-lipophilic balance (HLB) value of less than 10.
Additionally, he has created a tastemasked liquid pharmaceutical delivery system. This system is formulated to be substantially tasteless and includes a high osmolarity aqueous system that contains water, a sugar derivative, hydrogenated maltose syrup, and a polyhydroxy alcohol, presenting an innovative approach to pharmaceutical delivery.
Career Highlights
Throughout his career, Thomas has collaborated with prominent companies such as K.V. Pharmaceutical Company and KV Pharmaceuticals Company, where he honed his skills and applied his inventive talents. His work has led to advancements in pharmaceutical formulations, significantly benefiting the field.
Collaborations
Thomas has worked alongside several notable professionals, including Robert C. Cuca and Keith S. Lienhop. These collaborations have further enriched his experience and contributed to the success of the projects he undertook.
Conclusion
Thomas Charles Riley, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive portfolio of six patents, he continues to push the boundaries of technology and improve patient care through effective pharmaceutical solutions. His extensive contributions reflect his commitment to enhancing healthcare and delivering better outcomes for patients worldwide.